“…Phospholipase A2 (PLA2) is the primary HBV enzyme, while hyaluronidase, acid phosphomonoesterase, lysophospholipase, and α-glucosidase are also present, but in a much lower amounts. Other non-peptide components affecting many cellular systems can be detected in HBV, including histamine, dopamine, norepinephrine, sugars such as fructose and glucose, and phospholipids [ 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 ]. HBV is under investigation for different diseases as a fundamental or adjuvant treatment, such as Parkinson’s disease, amyotrophic lateral sclerosis, multiple sclerosis, hepatic fibrosis, atherosclerosis, acne vulgaris, pain, lupus nephritis, periodontal diseases, and several cancers.…”